Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study - 11/04/24

Key words : adverse events, biologics, clinical efficacy, dupilumab, prurigo nodularis, real-world
| Drs Yi and Cao contributed equally to this article. |
|
| Funding sources: Supported by funding provided by the National Natural Science Foundation of China (grant numbers 82173424, 81974476, 81830096, and 82073458) and by the Program of Introducing Talents of Discipline to Universities (111 Project, number B20017). |
|
| IRB approval status: Reviewed and approved by the Ethic Committee of the Xiangya Hospital, Central South University (approval #202212806). |
Vol 90 - N° 5
P. 1076-1078 - mai 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
